Home | Neuromuscular | Duchenne muscular dystrophy (DMD) | Congress activities | American Academy of Neurology Annual Meeting (AAN)

American Academy of Neurology Annual Meeting (AAN)

View all AAN WMS MDA

The American Academy of Neurology (AAN) Annual Meeting is the world’s largest conference for neurology and neuroscience professionals.

Please select the resource of interest below:

Sort by:

AAN 2023 oral presentation: Evaluation of the biodistribution, efficacy, and side-effect profile of deflazacort, prednisolone and vamorolone in a DMD mouse model

This oral presentation at AAN 2023 explored the use of 3 corticosteroids in a Duchenne muscular dystrophy (DMD) mouse model. The study monitored pharmacokinetics and biodistribution, the efficacy on muscle function and damage, and explored potential side effects

American Academy of Neurology Annual Meeting (AAN)

AAN 2023 oral presentation: Safety and efficacy of ataluren in nmDMD patients from Study 041, a phase 3, randomized, double-blind, placebo-controlled trial

This AAN 2023 oral presentation focused on ataluren use for the treatment of nonsense mutation Duchene muscular dystrophy (nmDMD) patients. The symposium detailed the efficacy and safety profile of ataluren in Study 041

Year

2023

Congress

AAN

Therapy area

Duchenne muscular dystrophy

American Academy of Neurology Annual Meeting (AAN)

Authenticating...

COMING SOON